Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hartmann

Showing results (211-220 of 472) with videos related to

Pageof 48
Sort By:
Anti-Cancer Drugs|April 11, 2000
The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumorsJ T Hartmann, S Knop, L M Fels, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2009
High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumorsA Lorch, A Neubauer, M Hackenthal, et al.
Investigational New Drugs|July 6, 2012
Pemetrexed in patients with refractory soft tissue sarcoma: a non-comparative multicenter phase II study of the German Sarcoma Group AIO-STS 005J T Hartmann, S Bauer, G Egerer, et al.
Investigational New Drugs|September 1, 2005
An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcomaJ T Hartmann, K Oechsle, J Huober, et al.
Anesthesiology|September 15, 1999
A new noninvasive method to measure blood pressure: results of a multicenter trialK Belani, M Ozaki, J Hynson, et al.
Anti-Cancer Drugs|February 1, 2007
An open-label, multicenter phase II trial of capecitabine in patients with cisplatin-refractory or relapsed germ cell tumorsKarin Oechsle, Friedemann Honecker, Christian Kollmannsberger, et al.
British Journal of Anaesthesia|September 29, 2001
Waste gas exposure to sevoflurane and nitrous oxide during anaesthesia using the oesophageal-tracheal Combitube small adultK H Hoerauf, T Hartmann, S Acimovic, et al.
American Journal of Respiratory Cell and Molecular Biology|August 1, 1995
Tryptase, the dominant secretory granular protein in human mast cells, is a potent mitogen for cultured dog tracheal smooth muscle cellsJ K Brown, C L Tyler, C A Jones, et al.
La Revue De Medecine Interne|March 31, 2004
[Complete remission obtained with letrozole in a man with metastatic breast cancer]A Italiano, R Largillier, P-Y Marcy, et al.
Oncology|March 11, 2010
Patterns of relapse after chemotherapy in patients with high-risk non-seminomatous germ cell tumorKarin Oechsle, Anja Lorch, Friedemann Honecker, et al.
Pageof 48

Showing results (211-220 of 472) with videos related to

Sort By:
Pageof 48
Anti-Cancer Drugs|April 11, 2000
The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumorsJ T Hartmann, S Knop, L M Fels, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2009
High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumorsA Lorch, A Neubauer, M Hackenthal, et al.
Investigational New Drugs|July 6, 2012
Pemetrexed in patients with refractory soft tissue sarcoma: a non-comparative multicenter phase II study of the German Sarcoma Group AIO-STS 005J T Hartmann, S Bauer, G Egerer, et al.
Investigational New Drugs|September 1, 2005
An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcomaJ T Hartmann, K Oechsle, J Huober, et al.
Anesthesiology|September 15, 1999
A new noninvasive method to measure blood pressure: results of a multicenter trialK Belani, M Ozaki, J Hynson, et al.
Anti-Cancer Drugs|February 1, 2007
An open-label, multicenter phase II trial of capecitabine in patients with cisplatin-refractory or relapsed germ cell tumorsKarin Oechsle, Friedemann Honecker, Christian Kollmannsberger, et al.
British Journal of Anaesthesia|September 29, 2001
Waste gas exposure to sevoflurane and nitrous oxide during anaesthesia using the oesophageal-tracheal Combitube small adultK H Hoerauf, T Hartmann, S Acimovic, et al.
American Journal of Respiratory Cell and Molecular Biology|August 1, 1995
Tryptase, the dominant secretory granular protein in human mast cells, is a potent mitogen for cultured dog tracheal smooth muscle cellsJ K Brown, C L Tyler, C A Jones, et al.
La Revue De Medecine Interne|March 31, 2004
[Complete remission obtained with letrozole in a man with metastatic breast cancer]A Italiano, R Largillier, P-Y Marcy, et al.
Oncology|March 11, 2010
Patterns of relapse after chemotherapy in patients with high-risk non-seminomatous germ cell tumorKarin Oechsle, Anja Lorch, Friedemann Honecker, et al.
Pageof 48